Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.

Abstract

Over 93% of 30 patients with metastatic high-risk gestational trophoblastic neoplasia treated initially with the EMA-CO protocol, often in conjunction with brain irradiation, surgical resection of sites of persistent tumor and salvage platinum-based chemotherapy, were cured.